Identify areas of high unmet need working with GEE and GMA as well as other cross-functional colleagues as needed
Define evidence generation requirements to quantify unmet need, how asset’s projected efficacy is to positively effect patient and health system outcomes
Conduct payer research to inform pricing and evidence requirements to address areas of high unmet need
Provide guidance to cross-functional colleagues, including new product planning, to maximize value of a given asset (indication prioritization)
Engage external experts (former or current payers and HTA assessors, clinical thought leaders) to better understand stakeholder perspective around unmet need and how to effectively optimize the asset’s value proposition
Draft asset’s value proposition; inform the asset’s target product profile; work with cross-functional colleagues as needed to inform the asset’s development programs across stage gates (including Ph 1, Ph 2 and Ph 3)
Seek input from regulators through EMA|HTA joint scientific advice to inform an asset’s development program
Engage with regional and affiliate market access colleagues, and other cross-functional colleagues as needed to develop global market access-related deliverables such as the global value dossier and relevant economic models
Establish global pricing and policy strategy
Inform asset launch sequence and early market access programs
Act as subject matter expertise on market access trends in major markets that impact on pricing potential and reimbursement for a given asset in development
Ensure value optimization is maintained post asset launch by working across regions to identify additional evidence generation required to bolster the asset’s global value proposition
Conduct and or support special projects as needed to stay current on global market access trends and implications to Shionogi portfolio
Requirements
Advanced degree such as MSc and/or PhD preferred
Minimum of 3 -5 years working in an affiliate-level Market Access team within the pharmaceutical, biotechnology, or healthcare industry (preferably the US)
Minimum of 7-10 years working in global Market Access teams within the pharmaceutical, biotechnology, or healthcare industry
Current on the latest market access trends including Joint Clinical Assessments and rapidly evolving pricing policies such as MFN
Deep subject matter expertise on the US healthcare system specific to market access preferred
Demonstrated expertise in developing and executing market access plans for pipeline assets in various disease areas such as orphan disease required
Experience conducting market-access related studies such as burden of disease studies, modeling, systematic literature reviews, and meta-analyses required
Proficiency working with clinical outcome assessment measures
Exhibit strong leadership skills with the ability to develop and execute a strategic vision for gHCVa within GSO
Demonstrate exceptional collaboration and teamwork skills, working effectively with global and regional cross-functional teams, including Development, Clinical, New Product Planning, Commercial, Medical Affairs, Regulatory, Epidemiology and Real World Evidence, and Market Access
Possess strong analytical and critical thinking skills
Possess excellent written and verbal communication skills
Strong presentation skills to deliver compelling presentations and represent the organization at conferences
Ability to communicate and influence effectively at all levels within the organization
Ability to engage and build strong relationships with external stakeholders, including but not limited to thought leaders and academic experts
Demonstrated ability to effectively manage multiple projects, prioritize tasks, meet deadlines, and adapt to changing priorities
Proficient in resource allocation, budget management, and project planning to ensure successful execution of projects
Actively participate in professional development opportunities and stay informed of the evolving